OT: A choice between [Design Issues]

posted by BEQool  – 2024-10-23 15:17 (169 d 09:27 ago) – Posting: # 24248
Views: 3,631

Hello Helmut,

of course I unfortunately dont know the answers to your questions but

❝ [...] or PEs by model 3 (i.e., the conventional one with any group terms)? What would an assessor conclude from any of those? Even if they would calculate the CI of groups separately, likely they would overlap. So what?


Isnt it so that if we detect Group*Treatment interaction, the CIs of groups seperately very likely wouldnt overlap? That is why we detect an interaction?

BEQool

Complete thread:

UA Flag
Activity
 Admin contact
23,422 posts in 4,927 threads, 1,671 registered users;
27 visitors (0 registered, 27 guests [including 13 identified bots]).
Forum time: 00:45 CEST (Europe/Vienna)

To know the history of science is to recognize the mortality
of any claim to universal truth.    Evelyn Fox Keller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5